Correlation between Pten/p53 status and AKT pathway activity in BC and effect on clinical outcome Box plot for p53‐pathway activity in p53 wild‐type and.

Slides:

Advertisements

Similar presentations

Supplemental Figures Loss of circadian clock gene expression is associated with tumor progression in breast cancer Cristina Cadenas 1*, Leonie van de Sandt.

Advertisements

P

Table S1: The results of ER, PgR, and HER2 status in IHC testing and mRNA expression in the full Consortium population (N=389) HER2 statusER status PgR.

The expressions of H19 and Igf1r are significantly decreased in the eutopic endometrium of women with endometriosis compared to those without endometriosis.

Expression of follicular cell‐derived VEGF‐A and endothelial VEGFR is altered by different circulating TSH level Expression of follicular cell‐derived.

Figure 2. DNA methylation mediated MORT gene silencing is linked to luminal, receptor positive breast cancers. (A) MORT expression level plotted versus.

Transcriptional heterogeneity of breast cancer subtypes,

Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.

Network protein vulnerability in EGFR TKI‐resistant cells and specific for EGFR‐mutated cells. Network protein vulnerability in EGFR TKI‐resistant cells.

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.

Expression analyses of KLK7 mRNA in the brains of AD patients

MiR‐10b* down‐regulates the expression of BUB1, PLK1 and CCNA2 proteins in breast cancer cell lines.A.SPIN‐ordered expression matrix of miR‐10b* and its.

GLUT3 is a direct target of TCF4/β‐catenin

[68Ga]Pentixafor PET imaging of MM xenografts Real‐time PCR analysis of cxcr4 transcript expression levels in HeLa (negative control) and in MM cell lines.

The mRNA stem cell signature.

CAR T cell dose and percentages of CAR‐positive cells within CAR T cell products CAR T cell dose and percentages of CAR‐positive cells within CAR T cell.

BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Triple‐negative breast cancer (TNBC) cells in human express a specific gene signature and their self‐renewal depends on canonical Wnt/β‐catenin signalling.A.Human.

Human triple‐negative breast cancers (TNBC) express WNT10B, show active Wnt signalling and have high proliferation, and WNT10B has clinical relevance and.

IRE1 signaling signatures in glioblastoma multiform

Tumor intrinsic subtype is reflected in cancer-adjacent tissue.

Comparing histone profiles and DNA accessibility of secretory and enterocyte progenitor cells Comparing histone profiles and DNA accessibility of secretory.

IRE1 signaling signatures in glioblastoma multiform

SPP1 and TNC are induced by active JNK and promote lung metastasis

Volume 140, Issue 3, Pages e8 (March 2011)

B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.

Integrated protein co‐expression and differential expression across the ALS‐FTD disease continuum Integrated protein co‐expression and differential expression.

SPRY2 deficiency mediates CRPC

T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived model in a CXCR4‐dependent manner T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived.

Distribution of intrinsic subtypes among TNBC and distribution of TNBC among basal-like breast cancer. Distribution of intrinsic subtypes among TNBC and.

Direct dFOXO targets in wild‐type adult flies.

JNK signature in breast cancer cells is linked to ECM, stem cell, and wound healing gene networks and is enriched in basal‐like breast cancer JNK signature.

DOK7 gene therapy enhances life span and motor activity in ALS mice

PD-1 expression on HCC-infiltrating B cells and its clinical significance. PD-1 expression on HCC-infiltrating B cells and its clinical significance. A–H,

High frequency and unique tumor‐initiating cells (TICs) in Pten/p53‐deficient mice Flow cytometry profiles of indicated tumors with the CD24 and CD49f.

HMGB1 reverses mitochondrial DNA damage caused by mutant Atxn1 The mitochondrial DNA amplification assay with cerebellar tissue revealed that mitochondrial.

Schematic diagram of the proposed model depicting the functional relationship between EGFR and FASN in TKI resistance within EGFR mutant NSCLC cells Schematic.

Association of AIM2, RIG‐I and NLRP3 inflammasomes with better survival in NPC patients.A.Overexpression of ASC, caspase‐1 and IL‐1β proteins as well as.

Triple‐negative human breast cancers specifically express high levels of nuclear HMGA2, whose expression has clinical relevance and predicts recurrence‐free.

Potential relevance of SV‐eQTLs in adaptive or maladaptive pathways in heart failure Potential relevance of SV‐eQTLs in adaptive or maladaptive pathways.

FMRP is highly expressed in human breast cancer and distal metastasis FMRP expression on human TMAs containing normal and multi‐tumour tissues. FMRP is.

Endothelial Ang‐2 upregulation correlates with WHO grading in human gliomas Endothelial Ang‐2 upregulation correlates with WHO grading in human gliomas.

Down-regulation of LATS1 promotes the formation of tumors enriched in basal-like features. Down-regulation of LATS1 promotes the formation of tumors enriched.

BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.

Limited transcriptomic changes upon HOTAIR RNA overexpression in MDA‐MB‐231 breast cancer cells Limited transcriptomic changes upon HOTAIR RNA overexpression.

Characterising dermis expansion and gene expression changes during mouse development (related to Fig 1)‏ Characterising dermis expansion and gene expression.

Derivation and application of cancer‐specific epithelial‐mesenchymal transition (EMT) signature A six‐step scheme illustrating the generation of a cancer‐specific.

Application of tissue microarrays (TMAs) for the analysis of human glioma samples Application of tissue microarrays (TMAs) for the analysis of human glioma.

The antitumor activity of olaparib in PDXs identifies a subset of PARPi‐sensitive tumors The antitumor activity of olaparib in PDXs identifies a subset.

Patterns and regulation of age‐related splicing changes.

High CDK6 expression predicts poor prognosis in EOC patients

LXRα enhances glucose uptake and O‐GlcNAc signaling via activation of the hexosamine biosynthetic pathway (HBP) in cultured cardiomyocytes LXRα enhances.

Effect of rare SVs on cardiac transcription in DCM

P2X4R blockade increases pro‐inflammatory gene expression after EAE

DNMT3A1 signatures are not recapitulated in AML.

ADAM8 is overexpressed in human breast cancer AADAM8 mRNA expression in samples from breast tumor and normal breast tissue was analyzed using the Oncomine.

Tangle formation and downregulation of miR‐132‐3p in LOAD A‐G

DNMT3A2 signatures are coherently modified in AML.

ADAM8 is induced by hypoxia and promotes angiogenesis ASixteen h after plating, cells were cultured under normoxic (−) or hypoxic (+, 1% O2) conditions.

LATS2-associated gene expression pattern is down-regulated specifically in lumB breast tumors. LATS2-associated gene expression pattern is down-regulated.

(A) Distribution of LATS2 mRNA expression levels in different breast cancer subtypes (PAM50, METABTIC dataset); ***P-value < 0.001, t test comparing lumB.

SPRY2 deficiency mediates CRPC

Distinct molecular and clinical correlates of H3F3A mutation subgroups

PD-L1 expression correlates with T-cell markers and an IFN response signature in human melanomas. PD-L1 expression correlates with T-cell markers and an.

EN1 expression in breast cancer and clinical outcome.

ALDH1A3 expression levels are inversely correlated with the survival of patients with resectable mass-forming and advanced cholangiocarcinoma, respectively.

MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen. MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients.

Volume 28, Issue 3, Pages e7 (July 2019)

Construction of TME signatures and functional annotation.

Presentation transcript:

Correlation between Pten/p53 status and AKT pathway activity in BC and effect on clinical outcome Box plot for p53‐pathway activity in p53 wild‐type and p53 mutant tumors from GSE4922. Correlation between Pten/p53 status and AKT pathway activity in BC and effect on clinical outcome Box plot for p53‐pathway activity in p53 wild‐type and p53 mutant tumors from GSE4922. Median value of p53‐pathway activity for p53 mutant, 0.15, is lower than for wild‐type tumors (0.73; P = 6.5 × 10−15, Mann–Whitney U‐test). Pten gene expression and p53 pathway activity in human BC (PAM50 classification). Triple negative (TN) comprises claudin‐low, basal‐like and other subtypes. Number of tumors per group: TN, 471 (claudin low, 141; basal‐like, 330); HER2+, 218; LumA, 687; LumB, 672; Normal, 131. Percentage of samples with low Pten expression and low p53 pathway activity (Pten‐low and p53‐low) is indicated for each subtype. Pearson's correlation (r) with statistical significance (P‐value) for Pten gene expression versus p53 pathway activity is shown for indicated BC subtypes. Only TNBCs exhibited significantly higher % of samples with Pten‐low and p53‐low (P ≤ 5 × 10−6 relative the other subtypes) as well as positive correlation (P = 0.02). Kaplan–Meier metastasis‐free survival (% MFS) analysis showing that TNBC patients with Pten‐low:p53‐low tumors have poorer prognosis than Pten‐high:p53‐high tumors (P = 0.034, Wilcoxon). p53, PI3K and AKT pathway activities in mouse models (left) and human BC subtypes (right). Note the high and significant correlations of p53 and PI3K as well as p53 and AKT pathways in mouse Pten/p53 tumors and human claudin‐low TNBC. Box plot of AKT pathway activity in indicated mouse and human tumors. For mouse tumors, AKT pathway activity was significantly higher in Ptenf/f:p53f/f compared to p53f/f tumors (*P = 0.04, Kruskal–Wallis). Comparisons with other models gave lower P‐values. For human BC, AKT signaling was calculated for Pten/p53‐low tumors (left boxes) versus all other tumors (right boxes). Note the high Akt pathway activity in mouse Pten/p53 tumors relative to other models (P < 0.04) and a trend toward increased Akt signaling in human Pten‐low/p53‐low versus other claudin‐low tumors (P = 0.268). P‐values (Kruskal–Wallis) are shown. Kaplan–Meier metastasis‐free survival (% MFS) analysis showing that TNBC patients with AKT‐high:p53‐low tumors have poorer prognosis than AKT‐low:p53‐high tumors (P = 0.044, Wilcoxon). Jeff C Liu et al. EMBO Mol Med. 2014;6:1542-1560 © as stated in the article, figure or figure legend